GVHD after CAR T-cell therapy post allogeneic hematopoietic cell transplantation — successfully treated by extracorporeal photopheresis
IntroductionCAR T-cell therapy is highly effective, but also associated with unique toxicities. Because of the origin of T cells in patients who previously underwent allogeneic hematopoietic cell transplantation (alloHCT), graft-versus-host disease (GVHD) in the post-CAR T-cell setting poses a relev...
Saved in:
Main Authors: | Kiavasch Mohammad Nejad Farid, Gesine Bug, Anita Schmitt, Fabian Lang, Maria-Luisa Schubert, Uwe Haberkorn, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1500177/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extracorporeal photopheresis in stiff person syndrome
by: Yandy Marx Castillo-Aleman, et al.
Published: (2024-12-01) -
Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017–2019
by: Michael Girardi, et al.
Published: (2024-12-01) -
Allogeneic DNT cell therapy synergizes with T cells to promote anti-leukemic activities while suppressing GvHD
by: Jongbok Lee, et al.
Published: (2025-01-01) -
Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay
by: Ryosuke Arata, et al.
Published: (2025-01-01) -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES
by: Ugo Testa, et al.
Published: (2024-02-01)